Drug Utilization Review (DUR) Update
The Drug Utilization Review (DUR) website is temporarily inaccessible. Meeting notices will be posted on this page until the DUR website is operational again.

 

The purpose of the Iowa Medicaid Pharmacy webpage is to guide providers to available Iowa Medicaid Pharmacy resources.

 

Pharmaceutical and Therapeutics (P&T) Committee

To learn more about the P&T Committee, visit the Iowa Medicaid Preferred Drug List (PDL) website.

Drug Utilization Review (DUR) Committee

House File 653 established a requirement for the Pharmaceutical and Therapeutics (P&T) Committee and the Drug Utilization Review (DUR) Commission to request and consider information from individuals who possess scientific or medical training with respect to drugs and biological products for rare diseases and drugs and biological products that are genetically targeted when making recommendations or determinations regarding beneficiary access.